Pharmacists involved in CPAs may participate in clinical services that are outside the traditional field of practice of pharmacists. In particular, pharmacists are not required to participate in CPAs to provide many pharmacy practice services that are already covered by their traditional field of activity. B such as the management of pharmacotherapy, the provision of disease prevention services (p.B. vaccinations), participation in public health screenings (. B screening for depressive disorders in patients, such as . B major depressive disorders, such as major depressive disorders, by administering phQ-2), by providing education specific to the state of the disease (e.g. B as a certified diabetes educator) and advising patients on information about their medications.  Under the Standard Practice Agreement, a CPR has mandatory powers for controlled and non-controlled substances.  Pharmacists can help physicians treat chronic outpatient diseases in a variety of ways: Arkansan CPAs apply to individual pharmacists, practitioners called “licensed prescribing practitioners,” and patients.
The specific disease indicates that pharmacists will deal with the specified drugs that the pharmacist can use. Pharmacists are required to document their procedures for discussion with the collaborative practitioner and must keep these records for at least 2 years after the date of registration.  According to health researcher Karen E. Koch, the first invention of the term “collaborative management of drug treatments” dates back to William A. Zellmer`s publication in 1995 in the American Journal of Health-System Pharmacy.  The CDTM is an extension of the traditional field of pharmacists that enables pharmacist-based management of medication-related problems (PRDs) with an emphasis on a collaborative and interdisciplinary approach to the practice of healthcare pharmacy. The conditions for a CPA are set by the cooperating pharmacist and physician, although templates exist online. CPAs may be specific to a patient population of mutual interest, clinical situation or disease, and/or may describe an evidence-based protocol for the management of patient treatment regimens under CPA. .